| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 44 | 0.896 | |
| positive regulation of immune response | GO:0050778 | 159 | 0.752 | |
| regulation of leukocyte migration | GO:0002685 | 63 | 0.739 | |
| regulation of cytokine production | GO:0001817 | 232 | 0.729 | |
| positive regulation of macrophage chemotaxis | GO:0010759 | 3 | 0.711 | |
| complement component c5a signaling pathway | GO:0038178 | 1 | 0.710 | |
| myeloid leukocyte migration | GO:0097529 | 62 | 0.686 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.676 | |
| regulation of immune response | GO:0050776 | 201 | 0.627 | |
| innate immune response | GO:0045087 | 178 | 0.607 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 62 | 0.602 | |
| cytokine production | GO:0001816 | 247 | 0.588 | |
| granulocyte chemotaxis | GO:0071621 | 37 | 0.500 | |
| complement receptor mediated signaling pathway | GO:0002430 | 3 | 0.497 | |
| secretion | GO:0046903 | 254 | 0.480 | |
| regulation of macrophage chemotaxis | GO:0010758 | 4 | 0.479 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.439 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.420 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.377 | |
| response to lipid | GO:0033993 | 206 | 0.377 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.376 | |
| amine metabolic process | GO:0009308 | 44 | 0.366 | |
| regulation of t cell proliferation | GO:0042129 | 42 | 0.364 | |
| acute inflammatory response to antigenic stimulus | GO:0002438 | 1 | 0.364 | |
| response to other organism | GO:0051707 | 261 | 0.359 | |
| response to external biotic stimulus | GO:0043207 | 261 | 0.353 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.350 | |
| regulation of cell migration | GO:0030334 | 289 | 0.346 | |
| phagocytosis recognition | GO:0006910 | 3 | 0.337 | |
| response to molecule of bacterial origin | GO:0002237 | 82 | 0.327 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.312 | |
| positive regulation of response to external stimulus | GO:0032103 | 88 | 0.310 | |
| positive regulation of transport | GO:0051050 | 336 | 0.309 | |
| negative regulation of immune system process | GO:0002683 | 136 | 0.308 | |
| response to wounding | GO:0009611 | 168 | 0.308 | |
| regulation of leukocyte proliferation | GO:0070663 | 67 | 0.297 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.296 | |
| cation homeostasis | GO:0055080 | 189 | 0.293 | |
| regulation of defense response | GO:0031347 | 154 | 0.290 | |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.286 | |
| cellular response to biotic stimulus | GO:0071216 | 71 | 0.279 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 207 | 0.277 | |
| positive regulation of renal albumin absorption | GO:2000534 | 1 | 0.273 | |
| protein secretion | GO:0009306 | 98 | 0.251 | |
| immune system development | GO:0002520 | 195 | 0.250 | |
| taxis | GO:0042330 | 157 | 0.238 | |
| regulation of chemotaxis | GO:0050920 | 74 | 0.233 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 45 | 0.233 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.230 | |
| regulation of tumor necrosis factor production | GO:0032680 | 43 | 0.227 | |
| positive regulation of cell migration | GO:0030335 | 172 | 0.216 | |
| calcium mediated signaling | GO:0019722 | 44 | 0.216 | |
| tumor necrosis factor production | GO:0032640 | 43 | 0.213 | |
| coagulation | GO:0050817 | 78 | 0.211 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.210 | |
| secretion by cell | GO:0032940 | 226 | 0.205 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.201 | |
| chemokine c c motif ligand 21 signaling pathway | GO:0038116 | 1 | 0.201 | |
| vasculature development | GO:0001944 | 181 | 0.200 | |
| immune response | GO:0006955 | 307 | 0.197 | |
| positive regulation of chemotaxis | GO:0050921 | 57 | 0.192 | |
| cation transport | GO:0006812 | 331 | 0.192 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.191 | |
| hemostasis | GO:0007599 | 76 | 0.188 | |
| second messenger mediated signaling | GO:0019932 | 78 | 0.187 | |
| activation of immune response | GO:0002253 | 114 | 0.187 | |
| immune effector process | GO:0002252 | 159 | 0.187 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 45 | 0.184 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.183 | |
| defense response | GO:0006952 | 315 | 0.182 | |
| cellular homeostasis | GO:0019725 | 196 | 0.179 | |
| organic hydroxy compound transport | GO:0015850 | 63 | 0.178 | |
| adaptive immune response | GO:0002250 | 49 | 0.178 | |
| cellular response to lipopolysaccharide | GO:0071222 | 57 | 0.177 | |
| regulation of secretion | GO:0051046 | 194 | 0.176 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.175 | |
| regulation of protein transport | GO:0051223 | 213 | 0.175 | |
| positive regulation of acute inflammatory response | GO:0002675 | 2 | 0.173 | |
| positive regulation of behavior | GO:0048520 | 60 | 0.172 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 128 | 0.169 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.165 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 51 | 0.163 | |
| sensory perception of pain | GO:0019233 | 4 | 0.163 | |
| leukocyte proliferation | GO:0070661 | 74 | 0.163 | |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.162 | |
| regulation of erk1 and erk2 cascade | GO:0070372 | 99 | 0.162 | |
| cellular ion homeostasis | GO:0006873 | 168 | 0.160 | |
| wound healing | GO:0042060 | 115 | 0.157 | |
| regulation of lymphocyte proliferation | GO:0050670 | 64 | 0.156 | |
| positive regulation of camp metabolic process | GO:0030816 | 41 | 0.150 | |
| endocytosis | GO:0006897 | 159 | 0.146 | |
| single organismal cell cell adhesion | GO:0016337 | 148 | 0.146 | |
| sulfur compound metabolic process | GO:0006790 | 101 | 0.145 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.141 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.139 | |
| immune response activating signal transduction | GO:0002757 | 90 | 0.137 | |
| regulation of behavior | GO:0050795 | 82 | 0.137 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.136 | |
| response to bacterium | GO:0009617 | 144 | 0.134 | |
| regulation of adaptive immune response | GO:0002819 | 33 | 0.134 | |
| leukocyte chemotaxis | GO:0030595 | 76 | 0.133 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.132 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.131 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.131 | |
| regulation of vesicle mediated transport | GO:0060627 | 130 | 0.130 | |
| blood coagulation | GO:0007596 | 76 | 0.127 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.120 | |
| circulatory system development | GO:0072359 | 262 | 0.115 | |
| regulation of monocyte chemotaxis | GO:0090025 | 11 | 0.115 | |
| regulation of dendritic cell apoptotic process | GO:2000668 | 4 | 0.114 | |
| inflammatory response | GO:0006954 | 79 | 0.114 | |
| regulation of body fluid levels | GO:0050878 | 99 | 0.113 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.113 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.113 | |
| regulation of cytokine secretion | GO:0050707 | 57 | 0.112 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.112 | |
| regulation of hemostasis | GO:1900046 | 42 | 0.112 | |
| regulation of system process | GO:0044057 | 101 | 0.111 | |
| skeletal muscle satellite cell proliferation | GO:0014841 | 1 | 0.111 | |
| erk1 and erk2 cascade | GO:0070371 | 104 | 0.110 | |
| regulation of immune effector process | GO:0002697 | 91 | 0.109 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.106 | |
| exocytosis | GO:0006887 | 71 | 0.105 | |
| negative regulation of immune response | GO:0050777 | 40 | 0.105 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.104 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.104 | |
| biological adhesion | GO:0022610 | 331 | 0.100 | |
| endomembrane system organization | GO:0010256 | 196 | 0.099 | |
| negative regulation of cd8 positive alpha beta t cell activation | GO:2001186 | 1 | 0.097 | |
| neutrophil chemotaxis | GO:0030593 | 24 | 0.096 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.095 | |
| lymphocyte mediated immunity | GO:0002449 | 48 | 0.095 | |
| response to cytokine | GO:0034097 | 232 | 0.094 | |
| positive regulation of cytosolic calcium ion concentration | GO:0007204 | 82 | 0.094 | |
| positive regulation of lipopolysaccharide mediated signaling pathway | GO:0031666 | 4 | 0.093 | |
| lymphocyte activation | GO:0046649 | 133 | 0.093 | |
| chemotaxis | GO:0006935 | 157 | 0.092 | |
| regulation of cd8 positive alpha beta t cell activation | GO:2001185 | 2 | 0.092 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.091 | |
| blood vessel development | GO:0001568 | 172 | 0.091 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.091 | |
| serotonin secretion | GO:0001820 | 1 | 0.090 | |
| cell activation | GO:0001775 | 213 | 0.089 | |
| cellular response to triacyl bacterial lipopeptide | GO:0071727 | 2 | 0.089 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.089 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.088 | |
| muscle cell proliferation | GO:0033002 | 35 | 0.086 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.085 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.085 | |
| negative regulation of cytokine production | GO:0001818 | 82 | 0.083 | |
| regulation of mapk cascade | GO:0043408 | 262 | 0.082 | |
| astrocyte chemotaxis | GO:0035700 | 1 | 0.082 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.082 | |
| cell adhesion | GO:0007155 | 325 | 0.082 | |
| positive regulation of immunoglobulin mediated immune response | GO:0002891 | 4 | 0.080 | |
| metal ion homeostasis | GO:0055065 | 169 | 0.079 | |
| interferon alpha biosynthetic process | GO:0045349 | 4 | 0.079 | |
| angiogenesis | GO:0001525 | 147 | 0.078 | |
| receptor metabolic process | GO:0043112 | 81 | 0.078 | |
| humoral immune response | GO:0006959 | 49 | 0.078 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.076 | |
| leukocyte mediated immunity | GO:0002443 | 59 | 0.076 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.075 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.074 | |
| regulation of locomotion | GO:0040012 | 329 | 0.074 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 52 | 0.074 | |
| response to lipopolysaccharide | GO:0032496 | 70 | 0.073 | |
| positive regulation of mapk cascade | GO:0043410 | 190 | 0.073 | |
| granulocyte migration | GO:0097530 | 40 | 0.072 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.072 | |
| regulation of blood coagulation | GO:0030193 | 42 | 0.072 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.071 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.071 | |
| ion homeostasis | GO:0050801 | 230 | 0.070 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.070 | |
| regulation of leukocyte differentiation | GO:1902105 | 61 | 0.070 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 15 | 0.070 | |
| regulation of calcium mediated signaling | GO:0050848 | 17 | 0.069 | |
| negative regulation of immune effector process | GO:0002698 | 38 | 0.069 | |
| positive regulation of inflammatory response | GO:0050729 | 10 | 0.068 | |
| regulation of innate immune response | GO:0045088 | 97 | 0.068 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 41 | 0.067 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.066 | |
| negative regulation of angiogenesis | GO:0016525 | 39 | 0.066 | |
| negative regulation of positive chemotaxis | GO:0050928 | 1 | 0.066 | |
| positive regulation of secretion | GO:0051047 | 116 | 0.066 | |
| defense response to other organism | GO:0098542 | 129 | 0.066 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.065 | |
| regulation of interferon alpha biosynthetic process | GO:0045354 | 4 | 0.065 | |
| divalent inorganic cation homeostasis | GO:0072507 | 136 | 0.064 | |
| hemopoiesis | GO:0030097 | 180 | 0.064 | |
| positive regulation of cell death | GO:0010942 | 263 | 0.064 | |
| serotonin transport | GO:0006837 | 3 | 0.064 | |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.063 | |
| positive regulation of immune effector process | GO:0002699 | 40 | 0.063 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.063 | |
| cellular metal ion homeostasis | GO:0006875 | 146 | 0.062 | |
| negative regulation of vasculature development | GO:1901343 | 43 | 0.062 | |
| chemical homeostasis | GO:0048878 | 306 | 0.061 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.060 | |
| cellular response to lipid | GO:0071396 | 127 | 0.060 | |
| positive regulation of defense response | GO:0031349 | 87 | 0.060 | |
| regulation of cell activation | GO:0050865 | 125 | 0.059 | |
| response to interferon gamma | GO:0034341 | 39 | 0.059 | |
| peptidyl tyrosine modification | GO:0018212 | 170 | 0.058 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 48 | 0.058 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.058 | |
| t cell proliferation involved in immune response | GO:0002309 | 1 | 0.058 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 38 | 0.057 | |
| protein polymerization | GO:0051258 | 71 | 0.057 | |
| actin filament polymerization | GO:0030041 | 45 | 0.056 | |
| cellular calcium ion homeostasis | GO:0006874 | 117 | 0.056 | |
| mapk cascade | GO:0000165 | 288 | 0.056 | |
| signal release | GO:0023061 | 70 | 0.055 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.055 | |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.055 | |
| cell chemotaxis | GO:0060326 | 112 | 0.054 | |
| cardiovascular system development | GO:0072358 | 262 | 0.054 | |
| t cell activation | GO:0042110 | 99 | 0.054 | |
| regulation of protein localization | GO:0032880 | 296 | 0.053 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.052 | |
| lymphocyte proliferation | GO:0046651 | 70 | 0.052 | |
| monocyte chemotaxis | GO:0002548 | 20 | 0.052 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.052 | |
| response to oxidative stress | GO:0006979 | 121 | 0.052 | |
| response to growth factor | GO:0070848 | 205 | 0.052 | |
| positive regulation of lymphocyte proliferation | GO:0050671 | 46 | 0.052 | |
| positive regulation of tumor necrosis factor superfamily cytokine production | GO:1903557 | 22 | 0.052 | |
| t cell proliferation | GO:0042098 | 45 | 0.051 | |
| positive regulation of leukocyte chemotaxis | GO:0002690 | 38 | 0.051 | |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 26 | 0.051 | |
| calcium ion transport | GO:0006816 | 147 | 0.050 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 170 | 0.050 | |
| positive regulation of leukocyte migration | GO:0002687 | 46 | 0.050 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.050 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 162 | 0.050 | |
| muscle cell migration | GO:0014812 | 19 | 0.050 | |
| complement activation classical pathway | GO:0006958 | 3 | 0.049 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.049 | |
| organic anion transport | GO:0015711 | 103 | 0.048 | |
| negative regulation of alpha beta t cell activation | GO:0046636 | 3 | 0.048 | |
| negative regulation of leukocyte activation | GO:0002695 | 26 | 0.048 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 230 | 0.048 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.047 | |
| receptor mediated endocytosis | GO:0006898 | 84 | 0.047 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.047 | |
| regulation of smooth muscle cell chemotaxis | GO:0071671 | 2 | 0.046 | |
| regulation of vasculature development | GO:1901342 | 97 | 0.044 | |
| interferon gamma biosynthetic process | GO:0042095 | 8 | 0.044 | |
| membrane organization | GO:0061024 | 292 | 0.044 | |
| leukocyte migration | GO:0050900 | 107 | 0.044 | |
| blood circulation | GO:0008015 | 113 | 0.044 | |
| cellular cation homeostasis | GO:0030003 | 163 | 0.044 | |
| response to inorganic substance | GO:0010035 | 127 | 0.044 | |
| hormone secretion | GO:0046879 | 65 | 0.043 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.043 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.043 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 85 | 0.043 | |
| positive regulation of leukocyte activation | GO:0002696 | 80 | 0.043 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.042 | |
| leukocyte activation | GO:0045321 | 164 | 0.042 | |
| osteoclast development | GO:0036035 | 2 | 0.042 | |
| lipid metabolic process | GO:0006629 | 381 | 0.041 | |
| regulation of angiogenesis | GO:0045765 | 92 | 0.041 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 48 | 0.041 | |
| negative regulation of cell motility | GO:2000146 | 104 | 0.041 | |
| regulation of t cell mediated immunity | GO:0002709 | 18 | 0.041 | |
| positive regulation of protein secretion | GO:0050714 | 60 | 0.041 | |
| protein localization to membrane | GO:0072657 | 160 | 0.041 | |
| carbohydrate metabolic process | GO:0005975 | 207 | 0.041 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 29 | 0.040 | |
| positive regulation of camp dependent protein kinase activity | GO:2000481 | 4 | 0.040 | |
| regulation of cell motility | GO:2000145 | 299 | 0.040 | |
| interleukin 10 production | GO:0032613 | 17 | 0.040 | |
| metal ion transport | GO:0030001 | 272 | 0.039 | |
| negative regulation of cell activation | GO:0050866 | 33 | 0.039 | |
| calcium ion homeostasis | GO:0055074 | 122 | 0.039 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.039 | |
| nucleotide catabolic process | GO:0009166 | 408 | 0.039 | |
| system process | GO:0003008 | 349 | 0.039 | |
| glycerolipid metabolic process | GO:0046486 | 107 | 0.039 | |
| regulation of gamma delta t cell activation involved in immune response | GO:2001191 | 1 | 0.039 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 227 | 0.038 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 264 | 0.038 | |
| cell type specific apoptotic process | GO:0097285 | 125 | 0.038 | |
| actin filament based process | GO:0030029 | 224 | 0.038 | |
| response to hormone | GO:0009725 | 175 | 0.037 | |
| membrane disruption in other organism | GO:0051673 | 1 | 0.037 | |
| negative regulation of response to external stimulus | GO:0032102 | 83 | 0.037 | |
| positive regulation of erk1 and erk2 cascade | GO:0070374 | 75 | 0.037 | |
| sequestering of metal ion | GO:0051238 | 24 | 0.037 | |
| regulation of granulocyte chemotaxis | GO:0071622 | 16 | 0.036 | |
| regulation of hormone secretion | GO:0046883 | 57 | 0.036 | |
| leukocyte apoptotic process | GO:0071887 | 31 | 0.036 | |
| regulation of leukocyte activation | GO:0002694 | 115 | 0.035 | |
| regulation of mononuclear cell proliferation | GO:0032944 | 65 | 0.035 | |
| negative regulation of tumor necrosis factor production | GO:0032720 | 20 | 0.035 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.035 | |
| regulation of alpha beta t cell activation | GO:0046634 | 13 | 0.035 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.035 | |
| positive regulation of cell activation | GO:0050867 | 81 | 0.034 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.034 | |
| regulation of protein secretion | GO:0050708 | 86 | 0.034 | |
| detection of triacyl bacterial lipopeptide | GO:0042495 | 2 | 0.034 | |
| actin filament organization | GO:0007015 | 128 | 0.034 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 119 | 0.034 | |
| maintenance of location | GO:0051235 | 112 | 0.034 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.034 | |
| regulation of endocytosis | GO:0030100 | 72 | 0.033 | |
| neutrophil migration | GO:1990266 | 25 | 0.033 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 37 | 0.033 | |
| negative regulation of chemokine mediated signaling pathway | GO:0070100 | 5 | 0.033 | |
| regulation of myeloid cell differentiation | GO:0045637 | 81 | 0.033 | |
| t cell mediated immunity | GO:0002456 | 25 | 0.033 | |
| positive regulation of lipase activity | GO:0060193 | 28 | 0.033 | |
| regulation of acute inflammatory response | GO:0002673 | 13 | 0.033 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 48 | 0.033 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.033 | |
| cell surface pattern recognition receptor signaling pathway | GO:0002752 | 2 | 0.033 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 108 | 0.033 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.033 | |
| negative regulation of t cell cytokine production | GO:0002725 | 4 | 0.033 | |
| regulation of t cell activation | GO:0050863 | 77 | 0.032 | |
| positive regulation of myeloid leukocyte differentiation | GO:0002763 | 24 | 0.032 | |
| positive regulation of t cell activation | GO:0050870 | 54 | 0.032 | |
| negative regulation of defense response | GO:0031348 | 47 | 0.032 | |
| regulation of interferon gamma biosynthetic process | GO:0045072 | 8 | 0.032 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.032 | |
| negative regulation of platelet aggregation | GO:0090331 | 3 | 0.032 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 24 | 0.032 | |
| fc receptor signaling pathway | GO:0038093 | 2 | 0.031 | |
| regulation of ion transport | GO:0043269 | 189 | 0.031 | |
| regulation of cell killing | GO:0031341 | 22 | 0.031 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.031 | |
| cellular response to cytokine stimulus | GO:0071345 | 181 | 0.031 | |
| negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002823 | 8 | 0.031 | |
| post embryonic development | GO:0009791 | 2 | 0.031 | |
| response to organic cyclic compound | GO:0014070 | 204 | 0.030 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.030 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.030 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.030 | |
| regulation of acute inflammatory response to antigenic stimulus | GO:0002864 | 1 | 0.030 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.030 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.030 | |
| eosinophil activation involved in immune response | GO:0002278 | 2 | 0.030 | |
| regulation of cell adhesion | GO:0030155 | 166 | 0.029 | |
| regulation of sensory perception of pain | GO:0051930 | 3 | 0.029 | |
| negative regulation of t cell apoptotic process | GO:0070233 | 4 | 0.029 | |
| heterotypic cell cell adhesion | GO:0034113 | 28 | 0.029 | |
| response to virus | GO:0009615 | 126 | 0.029 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.029 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 40 | 0.029 | |
| fc receptor mediated inhibitory signaling pathway | GO:0002774 | 2 | 0.029 | |
| oxidation reduction process | GO:0055114 | 396 | 0.028 | |
| positive regulation of mononuclear cell proliferation | GO:0032946 | 47 | 0.028 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.028 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 181 | 0.028 | |
| positive regulation of muscle adaptation | GO:0014744 | 1 | 0.028 | |
| negative regulation of dendritic cell apoptotic process | GO:2000669 | 3 | 0.028 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.028 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.027 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.027 | |
| negative regulation of interleukin 12 secretion | GO:2001183 | 1 | 0.027 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.027 | |
| immune response regulating signaling pathway | GO:0002764 | 97 | 0.027 | |
| negative regulation of chemotaxis | GO:0050922 | 13 | 0.027 | |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.027 | |
| positive regulation of intracellular transport | GO:0032388 | 104 | 0.027 | |
| eosinophil activation | GO:0043307 | 3 | 0.027 | |
| regulation of response to wounding | GO:1903034 | 101 | 0.027 | |
| positive regulation of corticosteroid hormone secretion | GO:2000848 | 5 | 0.027 | |
| regulation of leukocyte chemotaxis | GO:0002688 | 46 | 0.027 | |
| cell killing | GO:0001906 | 34 | 0.027 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 4 | 0.027 | |
| nucleoside catabolic process | GO:0009164 | 408 | 0.026 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.026 | |
| response to electrical stimulus | GO:0051602 | 1 | 0.026 | |
| activation of phospholipase d activity | GO:0031584 | 3 | 0.026 | |
| cellular response to abiotic stimulus | GO:0071214 | 117 | 0.026 | |
| mature natural killer cell chemotaxis | GO:0035782 | 1 | 0.026 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 19 | 0.026 | |
| divalent metal ion transport | GO:0070838 | 152 | 0.026 | |
| regulation of peptide secretion | GO:0002791 | 42 | 0.026 | |
| regulation of viral process | GO:0050792 | 103 | 0.026 | |
| response to nitrogen compound | GO:1901698 | 184 | 0.026 | |
| regulation of myeloid leukocyte mediated immunity | GO:0002886 | 4 | 0.025 | |
| positive regulation of angiogenesis | GO:0045766 | 51 | 0.025 | |
| negative regulation of homeostatic process | GO:0032845 | 59 | 0.025 | |
| cellular response to oxidative stress | GO:0034599 | 85 | 0.025 | |
| regulation of coagulation | GO:0050818 | 44 | 0.025 | |
| positive regulation of cell cell adhesion mediated by integrin | GO:0033634 | 3 | 0.025 | |
| negative regulation of myeloid cell differentiation | GO:0045638 | 42 | 0.025 | |
| negative regulation of mononuclear cell proliferation | GO:0032945 | 15 | 0.025 | |
| regulation of binding | GO:0051098 | 111 | 0.024 | |
| regulation of neutrophil chemotaxis | GO:0090022 | 10 | 0.024 | |
| response to fungus | GO:0009620 | 4 | 0.024 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.024 | |
| positive regulation of cytokine secretion | GO:0050715 | 42 | 0.024 | |
| negative regulation of t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell | GO:2001189 | 1 | 0.024 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.024 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.024 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 27 | 0.024 | |
| endothelial cell proliferation | GO:0001935 | 65 | 0.023 | |
| activation of protein kinase activity | GO:0032147 | 90 | 0.023 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.023 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.023 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.023 | |
| interferon beta production | GO:0032608 | 23 | 0.023 | |
| regulation of nucleotide metabolic process | GO:0006140 | 269 | 0.023 | |
| regulation of t cell mediated cytotoxicity | GO:0001914 | 8 | 0.023 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.023 | |
| defense response to virus | GO:0051607 | 71 | 0.023 | |
| cellular response to hormone stimulus | GO:0032870 | 125 | 0.023 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.023 | |
| biomineral tissue development | GO:0031214 | 39 | 0.023 | |
| single organism cellular localization | GO:1902580 | 332 | 0.023 | |
| smooth muscle cell proliferation | GO:0048659 | 28 | 0.023 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.023 | |
| response to oxygen levels | GO:0070482 | 100 | 0.022 | |
| positive regulation of cell cycle process | GO:0090068 | 106 | 0.022 | |
| negative regulation of g protein coupled receptor protein signaling pathway | GO:0045744 | 18 | 0.022 | |
| negative regulation of cd4 positive alpha beta t cell proliferation | GO:2000562 | 1 | 0.022 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 97 | 0.022 | |
| complement activation | GO:0006956 | 19 | 0.022 | |
| plasma membrane organization | GO:0007009 | 115 | 0.022 | |
| regulation of interleukin 10 production | GO:0032653 | 16 | 0.022 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.022 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.022 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.022 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.022 | |
| response to diacyl bacterial lipopeptide | GO:0071724 | 2 | 0.022 | |
| homotypic cell cell adhesion | GO:0034109 | 47 | 0.022 | |
| regulation of cell cell adhesion | GO:0022407 | 57 | 0.022 | |
| cholesterol transport | GO:0030301 | 39 | 0.021 | |
| positive regulation of monocyte chemotaxis | GO:0090026 | 10 | 0.021 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.021 | |
| cyclic nucleotide metabolic process | GO:0009187 | 82 | 0.021 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 85 | 0.021 | |
| response to tumor necrosis factor | GO:0034612 | 76 | 0.021 | |
| actin polymerization or depolymerization | GO:0008154 | 56 | 0.021 | |
| plasma lipoprotein particle clearance | GO:0034381 | 16 | 0.021 | |
| cell matrix adhesion | GO:0007160 | 85 | 0.021 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.021 | |
| positive regulation of natural killer cell chemotaxis | GO:2000503 | 5 | 0.021 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 33 | 0.021 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.021 | |
| single organism membrane organization | GO:0044802 | 268 | 0.020 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 63 | 0.020 | |
| positive regulation of lymphocyte activation | GO:0051251 | 73 | 0.020 | |
| negative regulation of osteoclast development | GO:2001205 | 1 | 0.020 | |
| cellular response to organic cyclic compound | GO:0071407 | 127 | 0.020 | |
| protein localization to organelle | GO:0033365 | 280 | 0.020 | |
| cell substrate adhesion | GO:0031589 | 132 | 0.020 | |
| reactive nitrogen species metabolic process | GO:2001057 | 3 | 0.020 | |
| receptor internalization | GO:0031623 | 43 | 0.020 | |
| cell morphogenesis | GO:0000902 | 296 | 0.020 | |
| regulation of interleukin 8 production | GO:0032677 | 49 | 0.020 | |
| hindbrain development | GO:0030902 | 3 | 0.020 | |
| type i interferon secretion | GO:0072641 | 1 | 0.019 | |
| positive regulation of protein kinase b signaling | GO:0051897 | 42 | 0.019 | |
| leukocyte activation involved in immune response | GO:0002366 | 30 | 0.019 | |
| regulation of heterotypic cell cell adhesion | GO:0034114 | 14 | 0.019 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.019 | |
| enzyme linked receptor protein signaling pathway | GO:0007167 | 303 | 0.019 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.019 | |
| negative regulation of interleukin 10 production | GO:0032693 | 7 | 0.019 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.019 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 32 | 0.019 | |
| behavior | GO:0007610 | 112 | 0.019 | |
| regulation of sensory perception | GO:0051931 | 3 | 0.019 | |
| regulation of peptide transport | GO:0090087 | 62 | 0.019 | |
| regulation of interleukin 12 secretion | GO:2001182 | 1 | 0.019 | |
| organic acid transport | GO:0015849 | 65 | 0.019 | |
| regulation of lymphocyte activation | GO:0051249 | 103 | 0.019 | |
| lymphocyte migration | GO:0072676 | 28 | 0.019 | |
| mononuclear cell proliferation | GO:0032943 | 71 | 0.019 | |
| negative regulation of eosinophil activation | GO:1902567 | 1 | 0.019 | |
| cytokine secretion | GO:0050663 | 64 | 0.019 | |
| regulation of inflammatory response | GO:0050727 | 46 | 0.018 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.018 | |
| regulation of smooth muscle cell proliferation | GO:0048660 | 28 | 0.018 | |
| regulation of calcium ion transport | GO:0051924 | 79 | 0.018 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.018 | |
| mineralocorticoid secretion | GO:0035931 | 1 | 0.018 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.018 | |
| cellular response to interferon gamma | GO:0071346 | 24 | 0.018 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 39 | 0.018 | |
| positive regulation of t cell proliferation | GO:0042102 | 33 | 0.018 | |
| positive regulation of cell adhesion | GO:0045785 | 84 | 0.018 | |
| viral genome replication | GO:0019079 | 50 | 0.018 | |
